| | 149647-78-9 Basic information More.. |
| Product Name: | Vorinostat | | Synonyms: | UNII-58IFB293JI;Octanediamide, N1-hydroxy-N8-phenyl-;SAHA=N-Hydroxy-N'-phenyloctanediamide;SAHA, N-Hydroxy-Nphenyloctanediamide, Zolinza;Zolinza (See Suberoylanilide Hydroxamic Acid);Vorinostat;N-Hyrdroxy-N'-phenyloctanediamide;Vorinostat for research | | CAS: | 149647-78-9 | | MF: | C14H20N2O3 | | MW: | 264.32 | | EINECS: | 682-505-1 | | Mol File: | 149647-78-9.mol |  |
Use
Vorinostat is a novel, molecularly targeted antineoplastic agent that causes cell cycle arrest and/or apoptosis by inhibiting histone deacetylase (hdac). it is the first hdac inhibitor approved by the us food and drug administration (fda) for the treatment of cutaneous t-cell lymphoma (ctcl) with significant skin involvement that is still progressing, resistant or relapsing after two systemic regimens.
- Vorinostat
-
- US $0.00-0.00 / KG
- 2024-04-12
- CAS:149647-78-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100MT
- Vorinostat
-
- US $0.00-0.00 / KG
- 2024-04-12
- CAS:149647-78-9
- Min. Order: 1KG
- Purity: 99%
- Supply Ability: 100MT
- Vorinostat
-
- US $0.00-0.00 / Gram
- 2024-04-12
- CAS:149647-78-9
- Min. Order: 1Gram
- Purity: 99%
- Supply Ability: 5KG
|
|
149647-78-9
Recommend Suppliers |
|